We are live on
!
Find out more
CAPTRUST Financial Advisors Portfolio holdings
AUM
$57.3B
1-Year Est. Return
18.32%
This Fund
S&P 500
This Quarter
Est. Return
+1.12%
1 Year Est. Return
+18.32%
3 Year Est. Return
+60%
5 Year Est. Return
+73.18%
10 Year Est. Return
+239.88%
AUM
$35B
AUM Growth
+$1.3B
(+3.9%)
Cap. Flow
+$1.38B
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
26.76%
Holding
2,434
New
144
Increased
1,196
Reduced
864
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$172M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$126M |
| 3 |
ResMed
RMD
|
+$95.1M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$80.7M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$68.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBTE
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
|
+$84.1M |
| 2 |
Distillate US Fundamental Stability & Value ETF
DSTL
|
+$49.6M |
| 3 |
Adobe
ADBE
|
+$47.9M |
| 4 |
Coca-Cola
KO
|
+$46.7M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$45.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.91% |
| 2 | Financials | 7.06% |
| 3 | Healthcare | 4.88% |
| 4 | Consumer Discretionary | 4.46% |
| 5 | Industrials | 3.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
AN2 Therapeutics
ANTX
$177M
| $39.6K | ﹤0.01% |
28,667
| – | – |
|
|
CGC
2252
Canopy Growth
CGC
$375M
| $37.5K | ﹤0.01% |
13,669
-3,718
| -21% | -$14.8K |
|
2253
Organogenesis Holdings
ORGO
$308M
| $37.3K | ﹤0.01% |
11,670
-939
| -7% | -$3.15K |
|
2254
Televisa
TV
$1.45B
| $37K | ﹤0.01% |
22,000
| – | – |
|
2255
Amplify Alternative Harvest ETF
MJ
$101M
| $36.5K | ﹤0.01% |
1,359
-225
| -14% | -$7.52K |
|
2256
AmeriServ Financial
ASRV
$73.6M
| $36.1K | ﹤0.01% |
13,483
| – | – |
|
|
DHY
2257
Credit Suisse High Yield Credit Fund
DHY
$238M
| $34.7K | ﹤0.01% |
16,205
+336
| +2% | +$737 |
|
2258
Imperial Petroleum
IMPP
$215M
| $33.9K | ﹤0.01% |
11,260
| – | – |
|
|
IRD
2259
Opus Genetics
IRD
$254M
| $33.3K | ﹤0.01% |
28,000
+10,000
| +56% | +$11.5K |
|
2260
Zentalis Pharmaceuticals
ZNTL
$308M
| $32.7K | ﹤0.01% |
+10,783
| New | +$35.3K |
|
2261
GSI Technology
GSIT
$216M
| $30.7K | ﹤0.01% |
10,130
| – | – |
|
2262
8x8 Inc
EGHT
$247M
| $30K | ﹤0.01% |
+11,253
| New | +$28.9K |
|
|
SGMO
2263
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $29.8K | ﹤0.01% |
+29,255
| New | +$53.5K |
|
2264
Aclarion
ACON
$5.96M
| $28.7K | ﹤0.01% |
22
-2
| -8% | -$3.05K |
|
2265
Dyadic International
DYAI
$43.4M
| $26.3K | ﹤0.01% |
15,000
| – | – |
|
2266
bioAffinity Technologies
BIAF
$4.15M
| $25.4K | ﹤0.01% |
930
| – | – |
|
|
ASRT
2267
DELISTED
Assertio
ASRT
| $25.1K | ﹤0.01% |
1,921
+427
| +29% | +$6.36K |
|
2268
Armata Pharmaceuticals
ARMP
$171M
| $24.3K | ﹤0.01% |
13,140
| – | – |
|
2269
Akebia Therapeutics
AKBA
$327M
| $24.2K | ﹤0.01% |
+12,711
| New | +$22.1K |
|
2270
FuboTV Inc
FUBO
$245M
| $23.2K | ﹤0.01% |
1,535
-802
| -34% | -$14.7K |
|
2271
E.W. Scripps
SSP
$274M
| $22.2K | ﹤0.01% |
+10,062
| New | +$23.2K |
|
2272
Kopin
KOPN
$663M
| $20.5K | ﹤0.01% |
+15,100
| New | +$14.5K |
|
2273
B2Gold
BTG
$5.16B
| $17.4K | ﹤0.01% |
+7,136
| New | +$21K |
|
|
BSIN
2274
Big Sky Industrial
BSIN
$67M
| $16.3K | ﹤0.01% |
10,000
| – | – |
|
2275
Coherus Oncology
CHRS
$217M
| $15.8K | ﹤0.01% |
11,485
-7,304
| -39% | -$8.19K |
|
Similar funds
NAMI
CAPTRUST Financial Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, CAPTRUST Financial Advisors held 2,434 positions worth $35B, up 3.9% from $33.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
CAPTRUST Financial Advisors deployed $1.38B of net new capital in Q4 2024, opening 144 new positions and adding to 1,196 existing holdings. Its largest new stake was NMI Holdings: 156,325 shares worth $5.75M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Distillate US Fundamental Stability & Value ETF, an estimated $49.6M trimmed.
- CAPTRUST Financial Advisors's largest Q4 2024 buy was NMI Holdings: 156,325 shares worth $5.75M.
- CAPTRUST Financial Advisors added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $172M increase.
- CAPTRUST Financial Advisors's biggest Q4 2024 reduction was Distillate US Fundamental Stability & Value ETF, cutting an estimated $49.6M.
- CAPTRUST Financial Advisors fully exited iShares iBonds Dec 2024 Term Treasury ETF in Q4 2024, selling an estimated $84.1M.
- CAPTRUST Financial Advisors's ten largest holdings make up 27% of its $35B portfolio in Q4 2024.
- CAPTRUST Financial Advisors opened 144 new positions and closed 143 in Q4 2024.
- CAPTRUST Financial Advisors's portfolio value rose 3.9% quarter-over-quarter to $35B.
Based on CAPTRUST Financial Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.